Advertisement

Psychopharmacology

, Volume 102, Issue 4, pp 459–464 | Cite as

D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaine

  • Hiroshi Ujike
  • Kazufumi Akiyama
  • Saburo Otsuki
Original Investigations

Abstract

A study was performed to examine behavioral response to a challenge of selective dopamine D-1 and D-2 agonists in rats previously sensitized by subchronic administration of methamphetamine or cocaine. Rats in three groups received repeated injections (IP) of saline, methamphetamine (4 mg/kg/day) or cocaine (20 mg/kg/day), respectively, for 14 days. After an abstinence period of 7–13 days, all groups were challenged with either a selective D-1 agonist (SKF 38393) or D-2 agonists (quinpirole or RU 24213). The ability of SKF 38393 (6 mg/kg or 18 mg/kg) to produce grooming behavior did not differ significantly among the saline-, methamphetamine-and cocaine-treated groups. In contrast, quinpirole (1 mg/kg) and RU 24213 (3 mg/kg) produced more intense stereotypy consisting of rearing, sniffing and repetitive head movement in the two psychostimulant-treated groups than in the saline-treated group. Such augmented response to selective D-2 agonists was observed even after a 1-month abstinence period. These results suggest that the enduring behavioral sensitization induced by two pharmacologically distinct psychostimulant agents, methamphetamine and cocaine, occurs through a common neurobiological mechanism of lasting supersensitivity in postsynaptic D-2, but not D-1 dopamine receptors.

Key words

Behavioral sensitization Methamphetamine Cocaine Quinpirole RU 24213 SKF 38393 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Akimoto K, Hamamura T, Otsuki S (1989) Subchronic cocaine treatment enhances cocaine-induced dopamine efflux, studied by in vivo intracerebral dialysis. Brain Res 490:339–344CrossRefPubMedGoogle Scholar
  2. Akiyama K, Sato M, Otsuki S (1982a) Increased3H-spiperone binding sites in mesolimbic area related to methamphetamine-induced behavioral sensitization. Biol Psychiatry 17:223–231PubMedGoogle Scholar
  3. Akiyama K, Sato M, Kashihara K, Otsuki S (1982b) Lasting changes in high affinity3H-spiperone binding to the rat striatum and mesolimbic area after chronic methamphetamine administration: evaluation of dopaminergic and serotonergic receptor compoonents. Biol Psychiatry 17:1389–1402PubMedGoogle Scholar
  4. Angrist B (1983) Psychosis induced by central nervous system stimulants and related drugs. In: Creese I (eds) Stimulants: neurochemical, behavioral and clinical perspectives. Raven Press, New York, pp 1–30Google Scholar
  5. Braun AR, Chase TN (1986) Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors. Eur J Pharmacol 131:301–306CrossRefPubMedGoogle Scholar
  6. Burt DR, Creese I, Snyder SH (1977) Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science 196:326–328PubMedGoogle Scholar
  7. Carson JH, Bergstrom DA, Walters JR (1987) Stimulation of both D1 and D2 dopamine receptors necessary for full expression of postsynaptic effects of dopamine agonists: a neurophysiological study. Brain Res 400:205–218CrossRefPubMedGoogle Scholar
  8. Clark S, Hjorth S, Carlsson A (1985) Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence. J Neural Transm 62:1–52CrossRefPubMedGoogle Scholar
  9. Ellinwood EH, Sudilovski A, Nelson LJ (1973) Evolving behavior in the clinical and experimental amphetamine (model) psychosis. Am J Psychiatry 130:1088–1093PubMedGoogle Scholar
  10. Howlett DR, Nahorski SR (1979) Acute and chronic amphetamine treatments modulate striatal dopamine receptor binding sites. Brain Res 161:173–178CrossRefPubMedGoogle Scholar
  11. Hulihan-Biblin B, Hauger RL, Janowski A, Paul SM (1985) Dopaminergic denervation increase [3H](+)-amphetamine binding in the rat striatum. Eur J Pharmacol 113:141–142CrossRefPubMedGoogle Scholar
  12. Jackson DM, Bailey RC, Christie MJ, Crisp EA, Skerritt JH (1981) Long-termd-amphetamine in rats: lack of a change in postsynaptic dopamine receptor sensitivity. Psychopharmacology 73:276–280PubMedGoogle Scholar
  13. Kazahaya Y, Akimoto K, Otsuki S (1989) Subchronic methamphetamine treatment enhances methamphetamine- or cocaine-induced dopamine efflux in vivo. Biol Psychiatry 25:903–912CrossRefPubMedGoogle Scholar
  14. Klawans HL, Hitri A, Carvey PM, Nausieda PA, Weiner WJ (1979) Effects of chronic dopaminergic agonist on striatal membrane dopamine binding. Adv Neurol 24:217–224Google Scholar
  15. Levy AD, Kim JJ, Ellison GD (1988) Chronic amphetamine alters D-2 but not D-1 agonist-induced behavioral response in rats. Life Sci 43:1207–1213CrossRefPubMedGoogle Scholar
  16. Mashurano M, Waddington JL (1986) Stereotyped behavior in response to the selective D-2 dopamine receptor agonist RU 24213 is enhanced by pretreatment with the selective D-1 agonist SK&F 38393. Neuropharmacology 25:947–949CrossRefPubMedGoogle Scholar
  17. Molloy AG, Waddington JL (1984) Dopaminergic behavior stereospecifically promoted by D1 agonist R-SK&F 38393 and selectively blocked by the D1 antagonist SCH 23390. Psychopharmacology 82:409–410CrossRefPubMedGoogle Scholar
  18. Moore KE (1976) The actions of amphetamine on neurotrans-mitters: a brief review. Biol Psychiatry 12:451–462Google Scholar
  19. Nishikawa T, Mataga N, Takashima M, Toru M (1983) Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment. Eur J Pharmacol 88:190–203Google Scholar
  20. Post RM, Kopanda RT (1976) Cocaine, kindling, and psychosis. Am J Psychiatry 133:627–634PubMedGoogle Scholar
  21. Post RM, Rose H (1976) Increasing effects of repetative cocaine administration in the rat. Nature 260:731–732CrossRefPubMedGoogle Scholar
  22. Pugh MT, O'Boyle KM, Molloy AG, Waddington JL (1985) Effects of the putative D-1 antagonist SCH 23390 on stereotyped behavior induced by the D-2 agonist RU 24213. Psychopharmacology 87:308–312Google Scholar
  23. Randrup A, Munkvad I (1970) Biochemical, anatomical and psychological investigations of stereotyped behavior induced by amphetamines. In Costa E, Garattini S (eds) Amphetamines and related compounds. Raven Press, New York, pp 695–713Google Scholar
  24. Reith MEA, Meisler BE, Sershen H, Lastha A (1986) Structural requirement for cocaine congeners to interact with dopamine and serotonin uptake site in mouse brain and to induce stereotyped behavior. Biochem Pharmacol 35:1123–1129CrossRefPubMedGoogle Scholar
  25. Riffee WH, Wilcox RE, Vaughn DM, Smith RV (1982) Dopamine receptor sensitivity after chronic dopamine agonists. Psychopharmacology 77:146–149CrossRefPubMedGoogle Scholar
  26. Robertson HA (1983) Chronicd-amphetamine and phencyclidine: effects on dopamine agonist and antagonist binding sites in the extrapyramidal and mesolimbic systems. Brain Res 267:179–182CrossRefPubMedGoogle Scholar
  27. Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 11:157–198CrossRefGoogle Scholar
  28. Robinson TE, Jurson PA, Bennett JA, Bentgen KM (1988) Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats. Brain Res 462:211–222CrossRefPubMedGoogle Scholar
  29. Sato M, Chen C-C, Akiyama K, Otsuki S (1983) Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biol Psychiatry 18:429–440PubMedGoogle Scholar
  30. Segal DS, Janowski DS (1978) Psychostimulant-induced behavioral effects: possible models of schizophrenia. In: Lipton MA, DiMascio A, Killam KF (eds) Psychopharmacology: a generation of progress. Raven Press, New York, pp 1113–1123Google Scholar
  31. Segal DS, Mandell AJ (1974) Long-term administration ofd-amphetamine: progressive augmentation of motor activity and stereotypy. Pharmacol Biochem Behav 2:249–255CrossRefPubMedGoogle Scholar
  32. Sharp T, Zetterstöm T, Collin A-K, Ungerstedt U (1987) The D-2 agonist quinpirole releases striatal dopamine in vivo. Eur J Pharmacol 142:187–188CrossRefPubMedGoogle Scholar
  33. Starr BS, Starr MS (1986) Differential effects of dopamine D1 and D2 agonists and antagonists on velocity of movement, rearing and grooming in the mouse. Neuropharmacology 25:455–463CrossRefPubMedGoogle Scholar
  34. Trugman JM, Geary II, Wooten GF (1986) Localization of D-2 dopamine receptors to intrinsic striatal neurons by quantitative autoradiography. Nature 323:267–269CrossRefPubMedGoogle Scholar
  35. Ujike H, Onoue T, Akiyama K, Hamamura T, Otsuki S (1989) Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization. Psychopharmacology 98:89–92Google Scholar
  36. Walters JR, Bergstrom DA, Carlson JH, Chase TN, Braun AR (1987) D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects. Science 236:719–722PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • Hiroshi Ujike
    • 1
  • Kazufumi Akiyama
    • 1
  • Saburo Otsuki
    • 1
  1. 1.Department of NeuropsychiatryOkayama University Medical SchoolOkayamaJapan

Personalised recommendations